Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chan

Showing results (351-360 of 449) with videos related to

Pageof 45
Sort By:
Cells|March 10, 2022
Illuminating Host-Parasite Interaction at the Cellular and Subcellular Levels with Infrared MicrospectroscopyHany M Elsheikha, Alaa T Al-Sandaqchi, Mohammad S R Harun, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 27, 2019
PTEN Activity Defines an Axis for Plasticity at Cortico-Amygdala Synapses and Influences Social BehaviorCristina Sánchez-Puelles, María Calleja-Felipe, Alberto Ouro, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 21, 2023
The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophreniaBłażej Misiak, Jerzy Samochowiec, Krzysztof Kowalski, et al.
The Lancet. Microbe|July 5, 2021
Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UKAngalee Nadesalingam, Diego Cantoni, David A Wells, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 28, 2019
Corrigendum to: -PTEN activity defines an axis for plasticity at cortico-amygdala synapses and influences social behaviorCristina Sánchez-Puelles, María Calleja-Felipe, Alberto Ouro, et al.
Gut|August 5, 2020
Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trialSuzanne E Mahady, Karen L Margolis, Andrew Chan, et al.
Neurology and Therapy|July 4, 2025
Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS StudyHeinz Wiendl, Frederik Barkhof, Xavier Montalban, et al.
Frontiers in Immunology|February 18, 2025
Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS studyHeinz Wiendl, Frederik Barkhof, Xavier Montalban, et al.
Frontiers in Immunology|March 20, 2025
Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS studyHeinz Wiendl, Frederik Barkhof, Xavier Montalban, et al.
Neurodegenerative Disease Management|April 7, 2026
A plain language summary on clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS studyKlaus Schmierer, Heinz Wiendl, Frederik Barkhof, et al.
Pageof 45

Showing results (351-360 of 449) with videos related to

Sort By:
Pageof 45
Cells|March 10, 2022
Illuminating Host-Parasite Interaction at the Cellular and Subcellular Levels with Infrared MicrospectroscopyHany M Elsheikha, Alaa T Al-Sandaqchi, Mohammad S R Harun, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 27, 2019
PTEN Activity Defines an Axis for Plasticity at Cortico-Amygdala Synapses and Influences Social BehaviorCristina Sánchez-Puelles, María Calleja-Felipe, Alberto Ouro, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 21, 2023
The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophreniaBłażej Misiak, Jerzy Samochowiec, Krzysztof Kowalski, et al.
The Lancet. Microbe|July 5, 2021
Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UKAngalee Nadesalingam, Diego Cantoni, David A Wells, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 28, 2019
Corrigendum to: -PTEN activity defines an axis for plasticity at cortico-amygdala synapses and influences social behaviorCristina Sánchez-Puelles, María Calleja-Felipe, Alberto Ouro, et al.
Gut|August 5, 2020
Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trialSuzanne E Mahady, Karen L Margolis, Andrew Chan, et al.
Neurology and Therapy|July 4, 2025
Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS StudyHeinz Wiendl, Frederik Barkhof, Xavier Montalban, et al.
Frontiers in Immunology|February 18, 2025
Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS studyHeinz Wiendl, Frederik Barkhof, Xavier Montalban, et al.
Frontiers in Immunology|March 20, 2025
Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS studyHeinz Wiendl, Frederik Barkhof, Xavier Montalban, et al.
Neurodegenerative Disease Management|April 7, 2026
A plain language summary on clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS studyKlaus Schmierer, Heinz Wiendl, Frederik Barkhof, et al.
Pageof 45